Cargando…

HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension

The impact of high-density lipoprotein (HDL) cholesterol on the development of atherosclerosis and diseases of systemic circulation has been well documented both in experimental and registry studies. Recent discoveries in pulmonary arterial hypertension (PAH) revealed a significant impact of HDL on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonas, Kamil, Kopeć, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678550/ https://www.ncbi.nlm.nih.gov/pubmed/31323735 http://dx.doi.org/10.3390/ijms20143514

Ejemplares similares

Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Jonas, Kamil, et al.
Publicado: (2019)

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2017)

Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio
por: Bilik, Mehmet Zihni, et al.
Publicado: (2022)

Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Magoń, Wojciech, et al.
Publicado: (2022)

Monocyte to HDL cholesterol ratio as a marker of the presence and severity of obstructive sleep apnea in hypertensive patients
por: Sun, Min, et al.
Publicado: (2021)

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Jonas, Kamil, et al.
Publicado: (2018)

Virtual Histology to Evaluate Mechanisms of Pulmonary Artery Lumen Enlargement in Response to Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension
por: Magoń, Wojciech, et al.
Publicado: (2020)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension
por: Waligóra, Marcin, et al.
Publicado: (2018)

Raising HDL cholesterol in women
por: Eapen, Danny J, et al.
Publicado: (2010)

Role of the Immune System Elements in Pulmonary Arterial Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2021)

Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension”
por: Waligóra, Marcin, et al.
Publicado: (2018)

The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension
por: Liontos, A., et al.
Publicado: (2022)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
por: Kjeldsen, Emilie W., et al.
Publicado: (2021)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

HDL cholesterol: reappraisal of its clinical relevance
por: März, Winfried, et al.
Publicado: (2017)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides
por: Higashi, Yukihito
Publicado: (2023)

High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients
por: Alcántara-Alonso, Estefanía, et al.
Publicado: (2021)

Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2013)

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis
por: Wang, Dianhui, et al.
Publicado: (2018)

Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients
por: Bleda, Silvia, et al.
Publicado: (2012)

In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?
por: Tomaszewski, Michał, et al.
Publicado: (2023)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study
por: Wang, Kun, et al.
Publicado: (2018)

Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis()()
por: Sirin, Mumtaz Cem, et al.
Publicado: (2020)

Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
por: Kılıç, Nülüfer, et al.
Publicado: (2023)

Is a High HDL-Cholesterol Level Always Beneficial?
por: Franczyk, Beata, et al.
Publicado: (2021)

Good Cholesterol Gone Bad? HDL and COVID-19
por: Kluck, George E. G., et al.
Publicado: (2021)

Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol–related inflammatory parameters as predictors
por: Guo, Xuantong, et al.
Publicado: (2022)

Myocardial proteomic profile in pulmonary arterial hypertension
por: Hołda, Mateusz K., et al.
Publicado: (2020)

Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the Polish multicentre registry (BNP-PL)
por: Jonas, Kamil, et al.
Publicado: (2023)

Coronary Artery Disease with Elevated Levels of HDL Cholesterol Is Associated with Distinct Lipid Signatures
por: Xia, Wanying, et al.
Publicado: (2023)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension
por: Waligóra, Marcin, et al.
Publicado: (2023)

Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
por: Bergmann, Katarzyna
Publicado: (2010)

Assessment of HDL Cholesterol Removal Capacity: Toward Clinical Application
por: Toh, Ryuji
Publicado: (2019)

Unravelling HDL—Looking beyond the Cholesterol Surface to the Quality Within
por: Kajani, Sarina, et al.
Publicado: (2018)

HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
por: Meikle, Peter J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jlvgqtm6k4mda5c3046lp0hsj4